James Mulshine, MD, is Professor, Internal Medicine, Rush Medical College. Previously Dr. Mulshine held positions at the National Cancer Institute (NCI), the Division of Cancer Prevention and Control, and the NCI-Navy Medical Oncology Branch. He is an internationally regarded expert in lung cancer.
His research interests include clinical trials in non-small cell lung cancer, tumor immunology (diagnostic or therapeutic applications of monoclonal antibodies); growth factor effects in human lung cancer; information systems; early cancer detection and cancer intervention research, and research facility design and construction.
The recipient of numerous honor and academic awards, Dr. Rush serves on the editorial board or as a reviewer for a number of academic publications, and has authored several hundred articles and books chapters.
Over the course of his career, Dr. Mulshine has chaired, co-chaired, and served as a member of numerous committees, evaluation groups, workshops, and meeting sessions. Most recently, in 2016 Dr. Rush served on the Organizing Committee for the AAMC GRAND Meeting, in Washington, D.C.; and as co-chair of the 17th World Conference on Lung Cancer (WCLC 2016), CT Screening Workshop in Vienna, Austria. He is also a member of the National Photonic Initiative National Technology Road Map Committee.
Dr. Rush received his MD degree from Loyola Stritch School of Medicine.
